A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction

NCT02220803 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Obstructive Sleep Apnea
Sleep-Disordered Breathing
Blood Pressure
Hypertension

Interventions

DRUG: Acetazolamide
DEVICE: nasal Continuous Positive Airway Pressure (nCPAP)

Sponsor

Göteborg University